ARTICLE | Product Development
Target, ligand and radioisotope choices fuel the growing field
By Karen Tkach Tuzman, Director of Biopharma Intelligence
December 1, 2023 1:15 AM UTC
The resurgence of targeted radiopharmaceuticals has created an ecosystem of companies testing combinatorial hypotheses about how best to align target, ligand and radioisotope choices to treat different cancers.
Ten years into its second wave, the field has seen four approvals and four $1B-plus acquisitions, and now has lines of sight to earlier treatment settings and blockbuster sales. …
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/650795/radiopharmaceuticals-multi-dimensional-next-wave